Literature DB >> 8140890

The nature and time course of neuronal vacuolation induced by the N-methyl-D-aspartate antagonist MK-801.

R N Auer1, K C Coulter.   

Abstract

N-Methyl-D-aspartate (NMDA) antagonists cause neuronal vacuolation in the posterior cingulate and retrosplenial cortex of the rat. Because the nature of neuronal pathologic changes due to NMDA antagonists may affect the potential clinical use of this class of drugs, we undertook experiments to define the nature and time course of the vacuolation caused by high-dose (5 mg/kg) MK-801 (dizocilpine, 5-methyl-10,11-dihydro-5H-dibenzo[a,d]cyclohepten-5,10-imine). Ultrastructural examination revealed the vacuoles to be not a form of hydropic cellular degeneration, but rather a dilatation of several intracellular compartments, chiefly endoplasmic reticulum and mitochondria. Study of the time course of the alterations revealed no light or ultrastructural features of neuronal necrosis in over 1 thousand neurons examined in layers 3 and 4 of the cingulate and retrosplenial cortex, 153 of which were vacuolated. The vacuoles resolved over time by decreasing in magnitude. Oxalate-pyroantimonate methodology revealed no redistribution of cell calcium in either vacuolated or non-vacuolated neurons. At 6 h, when vacuoles were consistently prominent in glutaraldehyde-fixed plastic-embedded tissue, a separate series of experiments was undertaken to vary methods of tissue preparation, and determine conditions under which vacuolation occurs. Frozen sections revealed no vacuoles. Subsequent paraffin embedding of the previously frozen tissue revealed no vacuoles, but vacuoles were seen in paraffin after perfusion fixation. Immersion fixation with brain refrigeration for 12 h prior to fixation revealed no vacuoles. Alcohol fixation also led to no visible vacuoles.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8140890     DOI: 10.1007/bf00386248

Source DB:  PubMed          Journal:  Acta Neuropathol        ISSN: 0001-6322            Impact factor:   17.088


  21 in total

1.  The subcellular distribution of calcium and the effects of calcium-antagonists as evaluated with a combined oxalate-pyroantimonate technique.

Authors:  M Borgers; F Thoné; J M van Nueten
Journal:  Acta Histochem Suppl       Date:  1981

2.  Cerebral blood flow and ischemia-induced neurotransmitter release in the striatum of aged spontaneously hypertensive rats.

Authors:  H Yao; H Ooboshi; S Ibayashi; H Uchimura; M Fujishima
Journal:  Stroke       Date:  1993-04       Impact factor: 7.914

3.  Immediate and long-lasting effects of MK-801 on motor activity, spatial navigation in a swimming pool and EEG in the rat.

Authors:  I Q Whishaw; R N Auer
Journal:  Psychopharmacology (Berl)       Date:  1989       Impact factor: 4.530

4.  Status epilepticus in well-oxygenated rats causes neuronal necrosis.

Authors:  G Nevander; M Ingvar; R Auer; B K Siesjö
Journal:  Ann Neurol       Date:  1985-09       Impact factor: 10.422

5.  Lack of effect of L-687,414 ((+)-cis-4-methyl-HA-966), an NMDA receptor antagonist acting at the glycine site, on cerebral glucose metabolism and cortical neuronal morphology.

Authors:  R J Hargreaves; M Rigby; D Smith; R G Hill
Journal:  Br J Pharmacol       Date:  1993-09       Impact factor: 8.739

6.  SL 82.0715, an NMDA antagonist acting at the polyamine site, does not induce neurotoxic effects on rat cortical neurons.

Authors:  D Duval; N Roome; C Gauffeny; J P Nowicki; B Scatton
Journal:  Neurosci Lett       Date:  1992-03-30       Impact factor: 3.046

7.  The glutamate antagonist MK-801 reduces focal ischemic brain damage in the rat.

Authors:  C K Park; D G Nehls; D I Graham; G M Teasdale; J McCulloch
Journal:  Ann Neurol       Date:  1988-10       Impact factor: 10.422

8.  Competitive (AP7) and non-competitive (MK-801) NMDA receptor antagonists differentially alter glucose utilization in rat cortex.

Authors:  D W Clow; S J Lee; R P Hammer
Journal:  Synapse       Date:  1991-04       Impact factor: 2.562

9.  MK-801 prevents hypobaric-ischemic neuronal degeneration in infant rat brain.

Authors:  J W Olney; C Ikonomidou; J L Mosinger; G Frierdich
Journal:  J Neurosci       Date:  1989-05       Impact factor: 6.167

10.  NMDA antagonist neurotoxicity: mechanism and prevention.

Authors:  J W Olney; J Labruyere; G Wang; D F Wozniak; M T Price; M A Sesma
Journal:  Science       Date:  1991-12-06       Impact factor: 47.728

View more
  7 in total

Review 1.  Management of neurogenic orthostatic hypotension: an update.

Authors:  Phillip A Low; Wolfgang Singer
Journal:  Lancet Neurol       Date:  2008-05       Impact factor: 44.182

2.  Discrete and reversible vacuole-like dilations induced by osmomechanical perturbation of neurons.

Authors:  C Reuzeau; L R Mills; J A Harris; C E Morris
Journal:  J Membr Biol       Date:  1995-05       Impact factor: 1.843

3.  S-sulfo-cysteine is an endogenous amino acid in neonatal rat brain but an unlikely mediator of cysteine neurotoxicity.

Authors:  Abdul-Karim Abbas; Wanlin Xia; Mattias Tranberg; Holger Wigström; Stephen G Weber; Mats Sandberg
Journal:  Neurochem Res       Date:  2007-09-01       Impact factor: 3.996

4.  Neuronal vacuole formation in the rat posterior cingulate/retrosplenial cortex after treatment with the N-methyl-D-aspartate (NMDA) antagonist MK-801 (dizocilpine maleate).

Authors:  A S Fix; J W Horn; L L Truex; R A Smith; E Gomez
Journal:  Acta Neuropathol       Date:  1994       Impact factor: 17.088

5.  Behavioural evaluation of long-term neurotoxic effects of NMDA receptor antagonists.

Authors:  W Zajaczkowski; M Hetman; E Nikolaev; G Quack; W Danysz; L Kaczmarek
Journal:  Neurotox Res       Date:  2000-04       Impact factor: 3.911

6.  Wallerian-like axonal degeneration in the optic nerve after excitotoxic retinal insult: an ultrastructural study.

Authors:  Sarabjit K Saggu; Hiren P Chotaliya; Peter C Blumbergs; Robert J Casson
Journal:  BMC Neurosci       Date:  2010-08-13       Impact factor: 3.288

Review 7.  Ketamine in the Past, Present, and Future: Mechanisms, Metabolites, and Toxicity.

Authors:  Eric S Schwenk; Basant Pradhan; Rohit Nalamasu; Lucas Stolle; Irving W Wainer; Michael Cirullo; Alexander Olsen; Joseph V Pergolizzi; Marc C Torjman; Eugene R Viscusi
Journal:  Curr Pain Headache Rep       Date:  2021-07-16
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.